Libo Sun
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Aging top 10%
Papers in
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 3
- RNA Research and Splicing 2
- Metabolomics and Mass Spectrometry Studies 2
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 7
- Co-authors
- Jian Li (4 shared papers)Bing Zhou (1 shared paper)Qiuli Liang (1 shared paper)Wei Li (1 shared paper)Xin Lin (4 shared papers)Juan Wang (1 shared paper)Xiuqing Huang (3 shared papers)Junpei Wang (2 shared papers)
- Journals
- Diabetes (2 papers)Cellular Physiology and Biochemistry (2 papers)Inflammation Research (1 paper)Scientific Reports (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Libo Sun
29 papers receiving 784 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 323
- Aging 22
- Molecular Biology 518
- Epidemiology 163
- Hepatology 37
Countries citing papers authored by Libo Sun
This map shows the geographic impact of Libo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Sun more than expected).
Fields of papers citing papers by Libo Sun
This network shows the impact of papers produced by Libo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Sun. The network helps show where Libo Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 118 | |
| 2 | 2018 | 89 | |
| 3 | 2018 | 82 | |
| 4 | 2017 | 73 | |
| 5 | 2020 | 47 | |
| 6 | 2008 | 44 | |
| 7 | 2018 | 44 | |
| 8 | 2016 | 37 | |
| 9 | 2007 | 33 | |
| 10 | 2017 | 32 | |
| 11 | 2015 | 29 | |
| 12 | 2021 | 27 | |
| 13 | 2020 | 22 | |
| 14 | 2016 | 20 | |
| 15 | 2014 | 19 | |
| 16 | 2021 | 11 | |
| 17 | 2015 | 9 | |
| 18 | 2016 | 8 | |
| 19 | Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma. | 2014 | 8 |
| 20 | 2018 | 8 |
About Libo Sun
Libo Sun is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Cell Biology and Oncology, having authored 29 papers that have together received 793 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers), Circular RNAs in diseases (3 papers), Hepatitis B Virus Studies (2 papers), RNA Research and Splicing (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Cancer Research (323 citations), Aging (22 citations), Molecular Biology (518 citations), Epidemiology (163 citations) and Hepatology (37 citations). Libo Sun has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Jian Li, Bing Zhou, Qiuli Liang, Wei Li, Xin Lin, Juan Wang, Xiuqing Huang, Junpei Wang, Qinghua Cui and Jichun Yang. Their work appears in journals such as Diabetes, Cellular Physiology and Biochemistry, Inflammation Research, Scientific Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.